Search

everythinglearnresearchcommunity

for

Search:↓

A teenager lost hair due to fluoxetine and sertraline, but it grew back after stopping these drugs and switching to a different one.

Trichotillomania is a challenging-to-treat impulse-control disorder where individuals pull out their hair, more common in females, with some treatments showing benefits.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

Hair pulling disorder is treated with therapy and medication; hair loss from tension can be reversed if caught early.

An older woman had false beliefs after taking a depression medication, which stopped when she stopped the medication.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Eating disorders are serious, often undiagnosed conditions requiring early treatment, with anorexia being the most deadly and binge-eating the most treatable.

The conclusion is that careful management of both psychiatric and skin conditions is crucial for HIV patients, using medication and interdisciplinary approaches.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

A patient's allergic reaction to clozapine resolved without stopping the medication, showing the importance of blood monitoring.

The study found three different timing patterns of symptoms in women with premenstrual dysphoric disorder.

Inositol was not more effective than a placebo in treating trichotillomania.

Clomipramine alone does not reduce overgrooming in cats with psychogenic alopecia.

Accurate diagnosis and timely, tailored treatments improve outcomes in obstetrics and gynecology.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

Doctors need to be better prepared to assess and treat obesity in patients.

Behavioral dermatology treats skin problems by considering both emotional and physical factors.

Recognizing and managing skin-related psychiatric disorders in children is crucial for effective treatment.

The new classification system for skin disorders emphasizes the importance of understanding a patient's awareness of their condition for better treatment.

Hair diseases can have psychological effects and should be treated with a combination of psychosomatic care, therapy, and medication.

Trichotillomania is often misdiagnosed as alopecia areata and can be treated effectively with N-acetylcysteine and psychotropic drugs.

Combining mood stabilizers with antipsychotics is more effective for treating children with bipolar disorder than using mood stabilizers alone.

Skin symptoms without a medical cause often reflect psychological stress and are influenced by culture, requiring a team approach for treatment.

Acne is a common skin condition that can be influenced by diet, lifestyle, and hormones, and requires a treatment approach that includes psychological considerations.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Women with schizophrenia on atypical antipsychotics are more likely to have polycystic ovarian syndrome (PCOS) than women without schizophrenia.

Trichotillomania can cause severe complications like hairballs in the stomach, needing surgery and psychiatric care.

Prolactin levels and gene polymorphism are not linked to vitiligo severity but are related to BMI.